The Ascension of Targeted Covalent Inhibitors-Reference-Cited by-同舟云学术

The Ascension of Targeted Covalent Inhibitors

Published:2022-04-19 Issue:8 Volume:65 Page:5886-5901
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Singh Juswinder¹^ORCID

Affiliation:

1. Ankaa Therapeutics, M2D2 Incubator, University of Massachusetts Medical School, 55 Lake Avenue North, Worcester, Massachusetts 01655, United States

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.1c02134

Reference113 articles.

1. Managing the challenge of chemically reactive metabolites in drug development

2. Covalent Modifiers: An Orthogonal Approach to Drug Design

3. The resurgence of covalent drugs

4. Mechanism of action of penicillins: a proposal based on their structural similarity to acyl-D-alanyl-D-alanine.

5. An oral SARS-CoV-2 M pro inhibitor clinical candidate for the treatment of COVID-19

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring the binding dynamics of covalent inhibitors within active site of PLpro in SARS-CoV-2;Computational Biology and Chemistry;2024-10

2. Recent advances in the design of small molecular drugs with acrylamides covalent warheads;Bioorganic & Medicinal Chemistry;2024-10

3. Development of Novel Indole-Based Covalent Inhibitors of TEAD as Potential Antiliver Cancer Agents;Journal of Medicinal Chemistry;2024-09-13

4. Structure-Aided Computational Design of Triazole-Based Targeted Covalent Inhibitors of Cruzipain;Molecules;2024-09-05

5. Advanced technologies for screening and identifying covalent inhibitors;TrAC Trends in Analytical Chemistry;2024-09